Safety and efficacy of denosumab in osteoporotic hemodialysed patients

Abstract

Our pilot experience highlights the safety and efficacy of denosumab in the treatment of osteoporosis in HD patients, potentially supporting its use to reduce the burden of fractures in this patient population.